Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

BM-41.0904: a potential new osteoanabolic agent

Sep. 23, 1997

New SERMs prepared at Lilly

Sep. 23, 1997

Abbott searches for squalene synthase inhibitors as hypolipidemics

Sep. 23, 1997

Novel progestins described by Gedeon Richter

Sep. 23, 1997

Levormeloxifene preclinical and clinical data presented

Sep. 22, 1997

Additional PLAs filed for INVICORP

Sep. 22, 1997

Eel calcitonin nasal spray evaluated in phase I

Sep. 22, 1997

Calcimimetic agent shown active in preclinical models of hyperparathyroidism

Sep. 22, 1997

Tiqueside inhibits cholesterol absorption and reduces LDL cholesterol in humans

Sep. 19, 1997

OGS compound for glycolipid storage disorders nears clinic

Sep. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...